We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $783M
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P
Everpure Inc
P
+$3.43M

Top Sells

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$11.2M
2
BAP icon
Credicorp
BAP
+$9.17M
3
NXT icon
Nextpower Inc. Common Stock
NXT
+$6.93M
4
XP icon
XP
XP
+$6.54M
5
STRL icon
Sterling Infrastructure
STRL
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
401
BioMarin Pharmaceuticals
BMRN
$12.6B
– –
-8,719
Closed -$493K
BTMD icon
402
Biote Corp
BTMD
$38.7M
– –
-272,400
Closed -$368K
BWA icon
403
BorgWarner
BWA
$13B
– –
-18,098
Closed -$982K
CASH icon
404
Pathward Financial
CASH
$1.61B
– –
-864
Closed -$77.1K
CDE icon
405
Coeur Mining
CDE
$20.5B
– –
-13,763
Closed -$258K
CMT icon
406
Core Molding Technologies
CMT
$209M
– –
-14,664
Closed -$328K
CPRX
407
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-450,580
Closed -$11.2M
CRD.A icon
408
Crawford & Co Class A
CRD.A
$617M
– –
-67,899
Closed -$677K
CSTL icon
409
Castle Biosciences
CSTL
$1.12B
– –
-3,759
Closed -$92.3K
CTSH icon
410
Cognizant
CTSH
$27.9B
– –
-4,300
Closed -$264K
FENC icon
411
Fennec Pharmaceuticals
FENC
$378M
– –
-18,343
Closed -$113K
FLS icon
412
Flowserve
FLS
$9.37B
– –
-44,497
Closed -$3.27M
GIC icon
413
Global Industrial
GIC
$1.54B
– –
-7,913
Closed -$249K
GILD icon
414
Gilead Sciences
GILD
$187B
– –
-12,332
Closed -$1.72M
XRN
415
Chiron Real Estate Inc
XRN
$478M
– –
-13,672
Closed -$452K
GSM icon
416
FerroAtlántica
GSM
$796M
– –
-32,579
Closed -$134K
HCA icon
417
HCA Healthcare
HCA
$92.9B
– –
-4,069
Closed -$1.93M
HCKT icon
418
Hackett Group
HCKT
$268M
– –
-76,921
Closed -$1M
HFWA icon
419
Heritage Financial
HFWA
$1.15B
– –
-27,300
Closed -$710K
HIG icon
420
Hartford Financial Services
HIG
$36.1B
– –
-18,696
Closed -$2.53M
HOMB icon
421
Home BancShares
HOMB
$5.95B
– –
-4,786
Closed -$129K
HRTG icon
422
Heritage Insurance Holdings
HRTG
$1.05B
– –
-5,914
Closed -$155K
INFU icon
423
InfuSystem Holdings
INFU
$249M
– –
-79,961
Closed -$738K
ITRG
424
Integra Resources
ITRG
$564M
– –
-93,348
Closed -$255K
ITRI icon
425
Itron
ITRI
$4B
– –
-45,491
Closed -$4.08M
15 16
17
18 19

Similar funds

CC
Converium Capital Montreal $783M AUM
CCG
Chatham Capital Group Savannah, Georgia $783M AUM 31.99% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $782M AUM 48.76% 1-Year Est. Return
LF
Lee Financial Dallas, Texas $783M AUM 23.98% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $783M AUM 19.25% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CWP
CFM Wealth Partners Austin, Texas $783M AUM 47.07% 1-Year Est. Return

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.